After Clyburn’s recent departure, Merck promotes Garay and Oosthuizen to key human health postsnews2022-02-16T14:58:12+00:00February 16th, 2022|Fierce Pharma|
Moderna plots 4 new Asia branches, local hiring spree to build its commercial footprint for life beyond COVID shotsnews2022-02-16T14:51:41+00:00February 16th, 2022|Fierce Pharma|
Califf’s confirmation as FDA chief gives biopharma industry a ‘steady hand’ at the agency: analystnews2022-02-15T19:42:21+00:00February 15th, 2022|Fierce Pharma|
How can pharma avoid HCP ‘promo fatigue’? With synchronized campaigns and storytellingnews2022-02-15T19:31:09+00:00February 15th, 2022|Fierce Pharma|
FDA wallops Indian drugmaker with warning letter blasting API quality, equipment cleanliness and morenews2022-02-15T19:22:25+00:00February 15th, 2022|Fierce Pharma|
Thermo Fisher dishes up $40M for Pennsylvania facility expansion, creating more than 100 jobsnews2022-02-15T18:06:05+00:00February 15th, 2022|Fierce Pharma|
ASCO GU: Amgen’s Lumakras posts encouraging results in pancreatic cancer, though not as dazzling as Mirati rivalnews2022-02-15T16:28:17+00:00February 15th, 2022|Fierce Pharma|
NIH-backed nasal nonaddictive pain prospect clears early testnews2022-02-15T15:06:49+00:00February 15th, 2022|Fierce Pharma|
Roche’s eye implant retains efficacy, schedule out to two yearsnews2022-02-15T15:02:30+00:00February 15th, 2022|Fierce Pharma|
Roche’s eye implant retains efficacy, schedule out to 2 yearsnews2022-02-15T15:02:30+00:00February 15th, 2022|Fierce Pharma|
